Prolonged progestin treatment induces the promoter of CDK inhibitor p21Cip1,Waf1 through activation of p53 in human breast and endometrial tumor cells

References

Page 1

	Year	Citations
WAF1, a potential mediator of p53 tumor suppression Wafik S. El‐Deiry, Takashi Tokino, Victor E. Velculescu, Cell	1993	8.4K
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases J. Wade Harper Cell Molecular PharmacologyG1 Cyclin-dependent KinasesSignal TransductionSignaling PathwayMolecular Pathway	1993	5.6K
p21 is a universal inhibitor of cyclin kinases Yue Xiong, Gregory J. Hannon, Hui Zhang, Nature Receptor Tyrosine KinaseCyclin KinasesAnti-cancer AgentTumor SuppressorMedicine	1993	3.4K
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation Jamil Momand, Gerard P. Zambetti, David C. Olson, Cell Oncogenic AgentMedicineMolecular BiologyP53 ProteinP53-mediated Transactivation	1992	3.1K
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain Wei Gu, R G Roeder Cell P53 C-terminal DomainMolecular BiologyMolecular BasisTumor SuppressorMedicine	1997	2.5K
Definition of a consensus binding site for p53 Wafik S. El‐Deiry, Scott E. Kern, Jennifer A. Pietenpol, Nature Genetics Natural SciencesDna ReplicationMolecular BiologyMolecular BaseTumor Biology	1992	2K
p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Todd Waldman, K. W. Kinzler, Bert Vogelstein PubMed Cell DeathPathologyP53-dependent G1 ArrestCell CycleP53-mediated G1 Arrest	1995	1.2K
Synergistic activation of transcription by CBP and p53 Wei Gu, Xiaolu Shi, Robert G. Roeder Nature Transcriptional RegulationCell RegulationSynergistic ActivationGene RegulationGene Expression	1997	596
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Wafik S. El‐Deiry, Takashi Tokino, Todd Waldman, PubMed Topological ControlCell Cycle InhibitorsPathologyCell CycleCancer Biology	1995	590
Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Ute M. Moll, G Riou, Arnold J. Levine Proceedings of the National Academy of Sciences Distinct MechanismsBreast OncologyPathologyP53 ProteinCancer Biology	1992	580

Page 1